INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 240 filers reported holding INSMED INC in Q3 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $8,660,750 | +19.7% | 343,000 | 0.0% | 0.05% | +19.0% |
Q2 2023 | $7,237,300 | +23.8% | 343,000 | 0.0% | 0.04% | +31.2% |
Q1 2023 | $5,848,150 | +1367.2% | 343,000 | +1619.3% | 0.03% | +1500.0% |
Q4 2022 | $398,601 | -7.3% | 19,950 | 0.0% | 0.00% | -33.3% |
Q3 2022 | $430,000 | -99.0% | 19,950 | -99.1% | 0.00% | -98.8% |
Q2 2022 | $42,516,000 | -16.1% | 2,156,001 | 0.0% | 0.24% | -17.2% |
Q1 2022 | $50,666,000 | -13.7% | 2,156,001 | 0.0% | 0.29% | +1.7% |
Q4 2021 | $58,729,000 | -1.1% | 2,156,001 | 0.0% | 0.29% | +9.6% |
Q3 2021 | $59,376,000 | -3.2% | 2,156,001 | 0.0% | 0.26% | -3.0% |
Q2 2021 | $61,360,000 | -16.4% | 2,156,001 | 0.0% | 0.27% | -15.4% |
Q1 2021 | $73,433,000 | +2.3% | 2,156,001 | 0.0% | 0.32% | +17.8% |
Q4 2020 | $71,773,000 | -1.7% | 2,156,001 | -5.1% | 0.27% | -7.5% |
Q3 2020 | $73,045,000 | -12.3% | 2,272,712 | -24.9% | 0.29% | -20.7% |
Q2 2020 | $83,319,000 | +71.8% | 3,025,384 | 0.0% | 0.37% | +23.1% |
Q1 2020 | $48,497,000 | -16.9% | 3,025,384 | +23.7% | 0.30% | -3.5% |
Q4 2019 | $58,393,000 | +48.5% | 2,445,265 | +9.7% | 0.31% | +15.7% |
Q3 2019 | $39,333,000 | -37.6% | 2,229,760 | -9.4% | 0.27% | -37.4% |
Q2 2019 | $63,033,000 | +4.4% | 2,462,216 | +18.5% | 0.43% | +10.6% |
Q1 2019 | $60,396,000 | +148.6% | 2,077,601 | +12.2% | 0.39% | +94.5% |
Q4 2018 | $24,298,000 | -35.1% | 1,851,982 | 0.0% | 0.20% | -19.4% |
Q3 2018 | $37,447,000 | +126.2% | 1,851,982 | +164.6% | 0.25% | +99.2% |
Q2 2018 | $16,555,000 | +5.0% | 700,000 | 0.0% | 0.12% | -7.5% |
Q1 2018 | $15,764,000 | -27.8% | 700,000 | 0.0% | 0.13% | -29.1% |
Q4 2017 | $21,826,000 | -0.1% | 700,000 | 0.0% | 0.19% | +6.8% |
Q3 2017 | $21,847,000 | +218.3% | 700,000 | +75.0% | 0.18% | +195.0% |
Q2 2017 | $6,864,000 | -2.0% | 400,000 | 0.0% | 0.06% | +5.3% |
Q1 2017 | $7,004,000 | +32.4% | 400,000 | 0.0% | 0.06% | +9.6% |
Q4 2016 | $5,292,000 | -8.9% | 400,000 | 0.0% | 0.05% | -1.9% |
Q3 2016 | $5,808,000 | -60.7% | 400,000 | -73.3% | 0.05% | -65.8% |
Q2 2016 | $14,790,000 | -22.2% | 1,500,000 | 0.0% | 0.16% | -22.5% |
Q1 2016 | $19,005,000 | +4.7% | 1,500,000 | +50.0% | 0.20% | +33.3% |
Q4 2015 | $18,150,000 | -38.3% | 1,000,000 | -36.8% | 0.15% | -44.9% |
Q3 2015 | $29,405,000 | -24.0% | 1,583,490 | 0.0% | 0.27% | -19.8% |
Q2 2015 | $38,669,000 | +17.4% | 1,583,490 | 0.0% | 0.34% | +23.7% |
Q1 2015 | $32,937,000 | +92.2% | 1,583,490 | +42.9% | 0.27% | +56.6% |
Q4 2014 | $17,138,000 | +18.5% | 1,107,850 | 0.0% | 0.18% | -3.8% |
Q3 2014 | $14,457,000 | +138.0% | 1,107,850 | +264.4% | 0.18% | +145.9% |
Q2 2014 | $6,075,000 | -42.4% | 304,050 | -45.1% | 0.07% | -44.8% |
Q1 2014 | $10,549,000 | -22.1% | 554,050 | -30.4% | 0.13% | -29.8% |
Q4 2013 | $13,538,000 | -8.3% | 796,378 | -15.8% | 0.19% | -9.0% |
Q3 2013 | $14,764,000 | +55.1% | 945,803 | +18.8% | 0.21% | +11.7% |
Q2 2013 | $9,518,000 | – | 795,803 | – | 0.19% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Asymmetry Capital Management, L.P. | 250,584 | $4,420,000 | 9.48% |
Palo Alto Investors LP | 7,239,649 | $127,707,000 | 8.51% |
Foresite Capital Management IV, LLC | 1,429,518 | $25,217,000 | 8.15% |
First Light Asset Management, LLC | 1,294,743 | $22,839,000 | 3.45% |
Foresite Capital Management II, LLC | 915,016 | $16,141,000 | 3.41% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 356,600 | $6,287,000 | 2.90% |
ACUTA CAPITAL PARTNERS, LLC | 220,000 | $3,881,000 | 2.80% |
EMERALD ADVISERS, LLC | 984,987 | $17,375,000 | 0.81% |
EMERALD MUTUAL FUND ADVISERS TRUST | 911,936 | $16,087,000 | 0.71% |
Rock Springs Capital Management LP | 890,000 | $15,700,000 | 0.63% |